Using a Mobile Application for Real-Time Collection of Patient-Reported Outcomes in Hepatopancreatobiliary Surgery within an ERAS® Pathway

Patient-reported outcomes (PROs) are essential for patient-centered health care. This pilot study implemented a mobile application customized to an hepatopancreatobiliary Enhanced Recovery After Surgery (ERAS®) program—a novel environment—for real-time collection of PROs, including ERAS® pathway compliance. Patients undergoing hepatectomy, distal pancreatectomy, or pancreaticoduodenectomy through the ERAS® program were prospectively enrolled over 10 months. The application provided education and questionnaires before surgery through 30 days postdischarge. Thresholds were set for initial adoption of the application (75%), PRO response rate (50%), and patient satisfaction (75%). Daily postdischarge health checks integrated customized responses to guide out-of-hospital care. Of 165 enrolled patients, 122 met inclusion criteria. Application adoption was 93 per cent (114/122) and in-hospital engagement remained high at 88 per cent (107/122). Patients completed 62 per cent of PRO on quality of life, postoperative pain, nausea, opioid consumption, and compliance to ERAS® pathway items, including ambulation and breathing exercises. During postcharge tracking, 12 patients reported that the application prevented a phone call to the hospital and three patients reported prevention of an emergency room visit. PRO collection through this mobile device created an integrated platform for comprehensive perioperative care, patient-initiated outcome tracking with automatic reporting, and real-time feedback for process change. Improving proactive outpatient management of complex patients through mobile technology could help restructure health-care delivery and improve resource utilization for all patients.

Download Full-text

Using a mobile application for real-time collection of patient reported outcomes in hepatopancreatobiliary surgery within an ERAS® pathway

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2019.03.044 ◽

2019 ◽

Vol 31 ◽

pp. 111-112

Author(s):

R.C. Pickens ◽

A. Cochran ◽

K. Tezber ◽

R. Berry ◽

E. Bhattacharya ◽

...

Keyword(s):

Real Time ◽

Mobile Application ◽

Patient Reported Outcomes ◽

Patient Reported ◽

Hepatopancreatobiliary Surgery

Download Full-text

Digital health application for real-time patient-reported outcomes during prostate radiotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.2_suppl.157 ◽

2016 ◽

Vol 34 (2_suppl) ◽

pp. 157-157 ◽

Cited By ~ 2

Author(s):

Daniel Xiao Yang ◽

Jackson Thea ◽

Yi An ◽

James B. Yu

Keyword(s):

Quality Of Life ◽

Real Time ◽

Mobile Applications ◽

Mobile Application ◽

Patient Reported Outcomes ◽

Digital Health ◽

Prostate Radiotherapy ◽

Patient Reported

157 Background: The use of digital health technology, including mobile applications, in the clinical setting is becoming increasingly more prevalent. Such technology is currently being explored as clinical research tools. While the side effects of prostate radiotherapy are well documented after treatment, there remains a paucity of data on patient-reported outcomes and changes in quality of life (QOL) during the treatment period. Therefore, mobile applications represent a practical platform to enable patient reporting in real-time during prostate radiotherapy. Methods: Using an existing open source code framework (Apple ResearchKit), we developed a novel mobile application that enables prostate cancer patients to report, either during or immediately following daily radiation treatment, changes in urinary, bowel, sexual, and hormonal QOL domains. The mobile application utilizes validated questions from the Expanded Prostate Index Composite for Clinical Practice (EPIC-CP) Survey, and allows for survey responses to be tracked over time throughout the treatment period and at routine follow up. Results: For the initial phase of our study, we are currently piloting the mobile application at a single institution with a goal of accruing 50 patients. Study results will be compared to data from traditional surveys, which are available at follow-up but impracticable for real-time symptom reporting. By ASCO 2016 Genitourinary Cancers Symposium, we plan to begin the second phase of our study where any patient can enroll online through a mobile software distribution platform (Apple App Store). Conclusions: We demonstrate the feasibility of using a mobile application to enable patients to report quality of life changes in real-time during prostate radiotherapy. Moreover, our application facilitates clinical trials where patient data collection can be automated and completed at scale. Future prospective studies are planned to evaluate validity of clinical trial data gathered through such methodology.

Download Full-text

“I Like the Idea of It…But Probably Wouldn’t Use It” - Health Care Provider Perspectives on Heart Failure mHealth: Qualitative Study (Preprint)

10.2196/preprints.18101 ◽

2020 ◽

Author(s):

Jennifer Dickman Portz ◽

Kelsey Lynett Ford ◽

Kira Elsbernd ◽

Christopher E Knoepke ◽

Kelsey Flint ◽

...

Keyword(s):

Heart Failure ◽

Health Care ◽

Qualitative Study ◽

Real Time ◽

Health Care Providers ◽

Patient Reported Outcomes ◽

Care Providers ◽

Time Data ◽

Patient Reported ◽

Real Time Data

BACKGROUND Many mobile health (mHealth) technologies exist for patients with heart failure (HF). However, HF mhealth lacks evidence of efficacy, caregiver involvement, and clinically useful real-time data. OBJECTIVE We aim to capture health care providers’ perceived value of HF mHealth, particularly for pairing patient–caregiver-generated data with clinical intervention to inform the design of future HF mHealth. METHODS This study is a subanalysis of a larger qualitative study based on interviewing patients with HF, their caregivers, and health care providers. This analysis included interviews with health care providers (N=20), focusing on their perceived usefulness of HF mHealth tools and interventions. RESULTS A total of 5 themes emerged: (1) bio-psychosocial-spiritual monitoring, (2) use of sensors, (3) interoperability, (4) data sharing, and (5) usefulness of patient-reported outcomes in practice. Providers remain interested in mHealth technologies for HF patients and their caregivers. However, providers report being unconvinced of the clinical usefulness of robust real-time patient-reported outcomes. CONCLUSIONS The use of assessments, sensors, and real-time data collection could provide value in patient care. Future research must continually explore how to maximize the utility of mHealth for HF patients, their caregivers, and health care providers.

Download Full-text

“I Like the Idea of It…But Probably Wouldn’t Use It” - Health Care Provider Perspectives on Heart Failure mHealth: Qualitative Study

JMIR Cardio ◽

10.2196/18101 ◽

2020 ◽

Vol 4 (1) ◽

pp. e18101

Author(s):

Jennifer Dickman Portz ◽

Kelsey Lynett Ford ◽

Kira Elsbernd ◽

Christopher E Knoepke ◽

Kelsey Flint ◽

...

Keyword(s):

Heart Failure ◽

Health Care ◽

Qualitative Study ◽

Real Time ◽

Health Care Providers ◽

Patient Reported Outcomes ◽

Care Providers ◽

Time Data ◽

Patient Reported ◽

Real Time Data

Background Many mobile health (mHealth) technologies exist for patients with heart failure (HF). However, HF mhealth lacks evidence of efficacy, caregiver involvement, and clinically useful real-time data. Objective We aim to capture health care providers’ perceived value of HF mHealth, particularly for pairing patient–caregiver-generated data with clinical intervention to inform the design of future HF mHealth. Methods This study is a subanalysis of a larger qualitative study based on interviewing patients with HF, their caregivers, and health care providers. This analysis included interviews with health care providers (N=20), focusing on their perceived usefulness of HF mHealth tools and interventions. Results A total of 5 themes emerged: (1) bio-psychosocial-spiritual monitoring, (2) use of sensors, (3) interoperability, (4) data sharing, and (5) usefulness of patient-reported outcomes in practice. Providers remain interested in mHealth technologies for HF patients and their caregivers. However, providers report being unconvinced of the clinical usefulness of robust real-time patient-reported outcomes. Conclusions The use of assessments, sensors, and real-time data collection could provide value in patient care. Future research must continually explore how to maximize the utility of mHealth for HF patients, their caregivers, and health care providers.

Download Full-text

Enhanced Recovery Experience After Orthopaedic Surgery: A Systematic Review of Patient-Reported Outcomes

International Journal of Medicine in Developing Countries ◽

10.24911/ijmdc.51-1544989841 ◽

2019 ◽

pp. 108-112

Author(s):

Muath Alturkistani ◽

Ali Alahmari ◽

Hussam Alhumaidi ◽

Mohammed Alharbi ◽

Alhanouf Alqernas ◽

...

Keyword(s):

Systematic Review ◽

Orthopaedic Surgery ◽

Patient Reported Outcomes ◽

Enhanced Recovery ◽

Patient Reported

Download Full-text

Patient-Reported Outcomes: Investing in Real-Time Intervention to Improve Care

Journal of Clinical Pathways ◽

10.25270/jcp.2019.04.00069 ◽

2019 ◽

Vol 5 (3) ◽

pp. 39-47

Author(s):

Diane Denny ◽

Brandon Bosch ◽

Morgan Hannaford ◽

Scott R Hartman

Keyword(s):

Real Time ◽

Patient Reported Outcomes ◽

Patient Reported

Download Full-text

Long-Term Efficacy, Visual Performance and Patient Reported Outcomes with a Trifocal Intraocular Lens: A Six-Year Follow-up

Journal of Clinical Medicine ◽

10.3390/jcm10092009 ◽

2021 ◽

Vol 10 (9) ◽

pp. 2009

Author(s):

Joaquín Fernández ◽

Manuel Rodríguez-Vallejo ◽

Javier Martinez ◽

Noemi Burguera ◽

David P. Piñero

Keyword(s):

Intraocular Lens ◽

Patient Reported Outcomes ◽

Phone Call ◽

Distortion Analysis ◽

Patient Reported ◽

Visual Function Questionnaire ◽

Secondary Objective ◽

Defocus Curve ◽

The Mean

(1) Background: To evaluate the efficacy at 6 years postoperative after the implantation of a trifocal intraocular lens (IOL) AT Lisa Tri 839MP. The secondary objective was to evaluate the contrast sensitivity defocus curve (CSDC), light distortion analysis (LDA), and patient reported outcomes (PROs). (2) Methods: Sixty-two subjects participated in phone call interviews to collect data regarding a visual function questionnaire (VF-14), a patient reported spectacle independence questionnaire (PRSIQ), and questions related to satisfaction and decision to be implanted with the same IOL. Thirty-seven of these subjects were consecutively invited to a study visit for measurement of their visual acuity (VA), CSDC, and LDA. (3) Results: The mean monocular distance corrected VA was −0.05, 0.08, and 0.05 logMAR at far and distances of 67 cm and 40 cm, respectively. These VAs were significantly superior to those reported in previous literature (p < 0.05). The total area under the CSDC was 2.29 logCS/m−1 and the light distortion index 18.82%. The mean VF-14 score was 94.73, with 19.4% of subjects requiring spectacles occasionally for near distances, and 88.9% considering the decision of being operated again; (4) Conclusions: Long-term AT LISA Tri 839MP IOL efficacy results were equal or better than those reported 12 months postoperatively in previous studies. The spectacle independence and satisfaction rates were comparable to those reported in short-term studies.

Download Full-text